Emil Jthe_art_of_giving_up@mastodon.social
Nov 14, 2026, 8:29 AM@penguin42 @regehr Hank Green has an interview on his youtube channel with an ex Theranos researcher and one thing that was said there was that the business case for diagnostic tools is weak because it's not selling a solution but selling a problem. The way to treat respiratory infections doesn't really hinge on the virus strain... Similarly, personal whole genome sequencing is not revolutionizing healthcare overall, it's mostly a toy with few specific applications I guess